Pfizer Inc. (New York, NY) and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their mRNA-based vaccine program being developed to help protect against SARS-CoV-2 (the virus that causes COVID-19), received Fast Track designation from the U.S. Food and Drug Administration (FDA). The two vaccine candidates are currently being … [Read more...]